PL417178A1 - Hydrat A aripiprazolu i sposób jego wytwarzania - Google Patents
Hydrat A aripiprazolu i sposób jego wytwarzaniaInfo
- Publication number
- PL417178A1 PL417178A1 PL417178A PL41717802A PL417178A1 PL 417178 A1 PL417178 A1 PL 417178A1 PL 417178 A PL417178 A PL 417178A PL 41717802 A PL41717802 A PL 41717802A PL 417178 A1 PL417178 A1 PL 417178A1
- Authority
- PL
- Poland
- Prior art keywords
- producing
- aripiprazole hydrate
- aripiprazole
- hydrate
- preparation
- Prior art date
Links
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004372 aripiprazole Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Przedmiotem wynalazku jest hydrat A aripiprazolu oraz sposób jego wytwarzania.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001290645 | 2001-09-25 | ||
JP2001-290645 | 2001-09-25 | ||
JP2001-348276 | 2001-11-14 | ||
JP2001348276 | 2001-11-14 | ||
CA2379005 | 2002-03-27 | ||
CA 2379005 CA2379005A1 (en) | 2001-09-25 | 2002-03-27 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
PCT/JP2002/009858 WO2003026659A1 (en) | 2001-09-25 | 2002-09-25 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
PL417178A1 true PL417178A1 (pl) | 2016-07-04 |
PL230869B1 PL230869B1 (pl) | 2018-12-31 |
Family
ID=36049773
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL393603A PL221536B1 (pl) | 2001-09-25 | 2002-09-25 | Kryształy C bezwodnego aripiprazolu i sposób ich wytwarzania oraz zawierające je kompozycja farmaceutyczna i farmaceutyczny stały preparat doustny |
PL393596A PL393596A1 (pl) | 2001-09-25 | 2002-09-25 | Kryształy G bezwodnego aripiprazolu i sposób ich wytwarzania oraz kompozycja farmaceutyczna je zawierająca, farmaceutyczny stały preparat doustny i sposób jego wytwarzania oraz sposób wytwarzania granulek |
PL393608A PL219564B1 (pl) | 2001-09-25 | 2002-09-25 | Kryształy E bezwodnego aripiprazolu, sposób ich wytwarzania, kompozycja farmaceutyczna i farmaceutyczny stały preparat doustny zawierające kryształy E bezwodnego aripiprazolu |
PL393601A PL219565B1 (pl) | 2001-09-25 | 2002-09-25 | Kryształy D bezwodnego aripiprazolu, sposób ich wytwarzania, kompozycja farmaceutyczna i farmaceutyczny stały preparat doustny zawierające kryształy D bezwodnego aripiprazolu |
PL417178A PL230869B1 (pl) | 2001-09-25 | 2002-09-25 | Hydrat A aripiprazolu i sposób jego wytwarzania |
PL393598A PL221521B1 (pl) | 2001-09-25 | 2002-09-25 | Kryształy F bezwodnego aripiprazolu i sposób ich wytwarzania oraz zawierające je kompozycja farmaceutyczna i farmaceutyczny stały preparat doustny |
PL393607A PL393607A1 (pl) | 2001-09-25 | 2002-09-25 | Sposób wytwarzania granulek farmaceutycznego stałego preparat doustnego i sposób wytwarzania farmaceutycznego stałego preparatu doustnego oraz farmaceutyczny stały preparat doustny |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL393603A PL221536B1 (pl) | 2001-09-25 | 2002-09-25 | Kryształy C bezwodnego aripiprazolu i sposób ich wytwarzania oraz zawierające je kompozycja farmaceutyczna i farmaceutyczny stały preparat doustny |
PL393596A PL393596A1 (pl) | 2001-09-25 | 2002-09-25 | Kryształy G bezwodnego aripiprazolu i sposób ich wytwarzania oraz kompozycja farmaceutyczna je zawierająca, farmaceutyczny stały preparat doustny i sposób jego wytwarzania oraz sposób wytwarzania granulek |
PL393608A PL219564B1 (pl) | 2001-09-25 | 2002-09-25 | Kryształy E bezwodnego aripiprazolu, sposób ich wytwarzania, kompozycja farmaceutyczna i farmaceutyczny stały preparat doustny zawierające kryształy E bezwodnego aripiprazolu |
PL393601A PL219565B1 (pl) | 2001-09-25 | 2002-09-25 | Kryształy D bezwodnego aripiprazolu, sposób ich wytwarzania, kompozycja farmaceutyczna i farmaceutyczny stały preparat doustny zawierające kryształy D bezwodnego aripiprazolu |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL393598A PL221521B1 (pl) | 2001-09-25 | 2002-09-25 | Kryształy F bezwodnego aripiprazolu i sposób ich wytwarzania oraz zawierające je kompozycja farmaceutyczna i farmaceutyczny stały preparat doustny |
PL393607A PL393607A1 (pl) | 2001-09-25 | 2002-09-25 | Sposób wytwarzania granulek farmaceutycznego stałego preparat doustnego i sposób wytwarzania farmaceutycznego stałego preparatu doustnego oraz farmaceutyczny stały preparat doustny |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP3081216A1 (pl) |
KR (2) | KR100530731B1 (pl) |
CN (12) | CN104306374A (pl) |
AR (3) | AR073111A2 (pl) |
CA (1) | CA2713466C (pl) |
CL (1) | CL2010000405A1 (pl) |
CY (4) | CY1110208T1 (pl) |
DK (1) | DK1925308T3 (pl) |
ES (1) | ES2596354T3 (pl) |
HK (14) | HK1203059A1 (pl) |
IL (3) | IL204707A (pl) |
LT (1) | LT1925308T (pl) |
MY (1) | MY138669A (pl) |
NO (1) | NO337844B1 (pl) |
PE (1) | PE20030445A1 (pl) |
PH (1) | PH12014500782A1 (pl) |
PL (7) | PL221536B1 (pl) |
PT (1) | PT1925308T (pl) |
RU (1) | RU2279429C2 (pl) |
SI (1) | SI1927357T1 (pl) |
TW (2) | TWI318572B (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005041937A2 (en) * | 2003-10-23 | 2005-05-12 | Otsuka Pharmaceutical Co., Ltd. | Controlled release sterile injectable aripiprazole formulation and method |
JOP20200109A1 (ar) * | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | مستحضر قابل للحقن |
KR102128883B1 (ko) * | 2019-10-02 | 2020-07-01 | (주)삼화바이오팜 | 고순도 아리피프라졸의 신규 결정형 및 이의 제조방법 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54130587A (en) | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
JP2608788B2 (ja) | 1988-10-31 | 1997-05-14 | 大塚製薬 株式会社 | 精神***病治療剤 |
US5006528A (en) | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
JP3638447B2 (ja) * | 1998-09-10 | 2005-04-13 | 積水ハウス株式会社 | 笠木取付金具および笠木取付構造 |
GB9930061D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Quinolone compounds for use in treating viral infections |
WO2001053258A1 (fr) * | 2000-01-20 | 2001-07-26 | Eisai Co., Ltd. | Composes azotes cycliques et compositions pharmaceutiques les contenant |
CA2311734C (en) * | 2000-04-12 | 2011-03-08 | Bristol-Myers Squibb Company | Flash-melt oral dosage formulation |
WO2003030868A1 (en) * | 2001-10-09 | 2003-04-17 | Bristol-Myers Squibb Company | Flashmelt oral dosage formulation |
JP4197088B2 (ja) | 2000-06-05 | 2008-12-17 | 電気化学工業株式会社 | 低密度かつ低ガス透過性六方晶窒化硼素焼結体及びその製造方法 |
JP2002193915A (ja) * | 2000-12-28 | 2002-07-10 | Otsuka Pharmaceut Co Ltd | ベンゼンスルフォナート化合物 |
-
2002
- 2002-09-20 PE PE2002000922A patent/PE20030445A1/es active IP Right Grant
- 2002-09-20 MY MYPI20023512A patent/MY138669A/en unknown
- 2002-09-23 TW TW091121771A patent/TWI318572B/zh not_active IP Right Cessation
- 2002-09-23 TW TW098116881A patent/TWI332839B/zh not_active IP Right Cessation
- 2002-09-25 LT LTEP08000358.5T patent/LT1925308T/lt unknown
- 2002-09-25 PL PL393603A patent/PL221536B1/pl unknown
- 2002-09-25 CN CN201410468156.2A patent/CN104306374A/zh active Pending
- 2002-09-25 CN CN2013100996412A patent/CN103191118A/zh active Pending
- 2002-09-25 PL PL393596A patent/PL393596A1/pl not_active Application Discontinuation
- 2002-09-25 DK DK08000358.5T patent/DK1925308T3/en active
- 2002-09-25 CN CN201410053619.9A patent/CN103751093A/zh active Pending
- 2002-09-25 PT PT80003585T patent/PT1925308T/pt unknown
- 2002-09-25 PL PL393608A patent/PL219564B1/pl unknown
- 2002-09-25 ES ES08000358.5T patent/ES2596354T3/es not_active Expired - Lifetime
- 2002-09-25 PL PL393601A patent/PL219565B1/pl unknown
- 2002-09-25 EP EP16169141.5A patent/EP3081216A1/en not_active Withdrawn
- 2002-09-25 PL PL417178A patent/PL230869B1/pl unknown
- 2002-09-25 CN CN201410053617.XA patent/CN103751118A/zh active Pending
- 2002-09-25 CN CN201310728318.7A patent/CN103755632B/zh not_active Expired - Fee Related
- 2002-09-25 CN CN201410053920.XA patent/CN103751119A/zh active Pending
- 2002-09-25 CN CN201510333215.XA patent/CN104945321A/zh active Pending
- 2002-09-25 RU RU2004126636/04A patent/RU2279429C2/ru not_active IP Right Cessation
- 2002-09-25 CA CA2713466A patent/CA2713466C/en not_active Expired - Lifetime
- 2002-09-25 CN CN201510615759.5A patent/CN105267151A/zh active Pending
- 2002-09-25 CN CN201310191361.4A patent/CN103288727B/zh not_active Expired - Lifetime
- 2002-09-25 CN CN2012100054661A patent/CN102579446A/zh active Pending
- 2002-09-25 SI SI200230906T patent/SI1927357T1/sl unknown
- 2002-09-25 PL PL393598A patent/PL221521B1/pl unknown
- 2002-09-25 PL PL393607A patent/PL393607A1/pl unknown
- 2002-09-25 CN CN201610186509.9A patent/CN105832677A/zh active Pending
- 2002-09-25 CN CN201410466919.XA patent/CN104306337A/zh active Pending
- 2002-09-25 KR KR10-2004-7007990A patent/KR100530731B1/ko not_active IP Right Cessation
- 2002-09-25 KR KR10-2003-7000818A patent/KR100490222B1/ko active IP Right Review Request
-
2004
- 2004-04-22 HK HK15103616.1A patent/HK1203059A1/xx unknown
- 2004-04-22 HK HK16111449.6A patent/HK1223043A1/zh unknown
- 2004-04-22 HK HK15103617.0A patent/HK1203060A1/xx unknown
-
2006
- 2006-12-14 HK HK06113738.4A patent/HK1092808A1/xx not_active IP Right Cessation
-
2009
- 2009-08-21 HK HK09107688.3A patent/HK1129889A1/xx not_active IP Right Cessation
- 2009-08-21 AR ARP090103228A patent/AR073111A2/es not_active Application Discontinuation
- 2009-08-21 HK HK09107690.9A patent/HK1129891A1/xx not_active IP Right Cessation
-
2010
- 2010-01-21 HK HK10100638.6A patent/HK1136959A1/xx not_active IP Right Cessation
- 2010-01-21 HK HK10100649.3A patent/HK1136960A1/xx not_active IP Right Cessation
- 2010-01-21 HK HK10100650.9A patent/HK1136961A1/xx not_active IP Right Cessation
- 2010-01-21 HK HK10100635.9A patent/HK1136958A1/xx not_active IP Right Cessation
- 2010-03-24 IL IL204707A patent/IL204707A/en not_active IP Right Cessation
- 2010-04-23 CL CL2010000405A patent/CL2010000405A1/es unknown
- 2010-06-11 CY CY20101100529T patent/CY1110208T1/el unknown
- 2010-06-11 CY CY20101100531T patent/CY1110070T1/el unknown
- 2010-06-11 CY CY20101100530T patent/CY1110212T1/el unknown
- 2010-07-05 CY CY20101100614T patent/CY1110244T1/el unknown
- 2010-07-05 AR ARP100102387A patent/AR077635A2/es not_active Application Discontinuation
-
2012
- 2012-08-15 AR ARP120102986A patent/AR087544A2/es not_active Application Discontinuation
-
2013
- 2013-04-23 IL IL225902A patent/IL225902A0/en unknown
- 2013-12-31 HK HK13114439.5A patent/HK1187048A1/zh not_active IP Right Cessation
-
2014
- 2014-04-08 PH PH12014500782A patent/PH12014500782A1/en unknown
- 2014-09-19 HK HK14109483.9A patent/HK1196128A1/zh not_active IP Right Cessation
- 2014-09-22 IL IL234770A patent/IL234770A0/en unknown
- 2014-10-06 NO NO20141193A patent/NO337844B1/no not_active IP Right Cessation
-
2015
- 2015-11-13 HK HK15111240.8A patent/HK1210468A1/xx unknown
-
2016
- 2016-03-23 HK HK16103439.5A patent/HK1215397A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE529409T1 (de) | Verfahren zur herstellung von kristallinen aripiprazolformen | |
NO20034969D0 (no) | Fremgangsmåte for fremstilling av olefiner | |
NO20030560D0 (no) | Fremgangsmåte for fremstilling av silikon | |
DE60220646D1 (de) | Verfahren zur herstellung von verbindungsprofilen | |
DE602005015174D1 (de) | Verfahren zur herstellung von montelukast-natrium | |
HUP0400382A3 (en) | Sustained-release composition and process for producing the same | |
DE60230908D1 (de) | Verfahren zur herstellung von polyarylenethern | |
PL371127A1 (pl) | Pochodne 6-amino-morfinianu, metody ich otrzymywania oraz ich zastosowania | |
ZA200400999B (en) | Process for the preparation of tolterodine. | |
MXPA04000446A (es) | 4-aminociclohexanoles sustituidos. | |
ATE296816T1 (de) | Verfahren zur herstellung von ethern, vorzugsweise von thf | |
EG23204A (en) | Process for the production of quinazolines. | |
PL417178A1 (pl) | Hydrat A aripiprazolu i sposób jego wytwarzania | |
IT1317722B1 (it) | Procedimento per la produzione di gas di sintesi. | |
DE50200870D1 (de) | Verfahren zur herstellung von hydroxyalkylpolysiloxanen | |
MXPA04004090A (es) | Compuestos substituidos de 1h-quinolin-2-ona. | |
MX234329B (es) | Metodo para producir n-fosfonometilglicina. | |
SG146645A1 (en) | Process for the synthesis of 6-amino-4-(3-chloro-4fluoro-phenylamino)-7- ethoxy-quinoline-3-carbonitrile | |
MXPA03008119A (es) | Metodo para la produccion de 2,6-dialquilmorfolinas n-sustituidas. | |
MXPA02003042A (es) | Proceso para prevenir formacion de incrustaciones. | |
MXPA03009684A (es) | Procedimiento para la preparacion de 2-(5-(4-fluorofenil)-3- piridilmetilaminometil)-cromano. | |
MXPA03009210A (es) | PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS. | |
NO20041942L (no) | Tappehakesystem for produksjonspakninger | |
IL158119A0 (en) | Method for the production of delta1-pyrrolines | |
EP1457568A4 (en) | PROCESS FOR PRODUCING 2'-DESOXYGUANOSINE |